Edwards Lifesciences CorporationEWNYSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+4.5%
5Y CAGR+7.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.5%/yr
vs +11.0%/yr prior
5Y CAGR
+7.2%/yr
Consistent
Acceleration
-6.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.08B | +2.5% |
| 2024 | $1.05B | +9.4% |
| 2023 | $962.90M | +1.9% |
| 2022 | $945.20M | +4.7% |
| 2021 | $903.10M | +18.7% |
| 2020 | $760.70M | +1.1% |
| 2019 | $752.70M | +21.0% |
| 2018 | $622.20M | +12.6% |
| 2017 | $552.60M | +25.0% |
| 2016 | $442.20M | - |